Macter International Limited (PSX:MACTER)
270.09
0.00 (0.00%)
At close: May 29, 2026
Macter International Market Cap
Macter International has a market cap or net worth of 12.37 billion as of May 29, 2026. Its market cap has decreased by -23.20% in one year.
Market Cap
12.37B
Enterprise Value
13.60B
Revenue
11.95B
Ranking
n/a
PE Ratio
15.17
Stock Price
270.09
Market Cap Chart
Since September 25, 2017, Macter International's market cap has increased from 3.37B to 12.37B, an increase of 267.22%. That is a compound annual growth rate of 16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 12.37B | -18.63% |
| Dec 31, 2025 | 15.21B | 3.23% |
| Dec 31, 2024 | 14.73B | 265.38% |
| Dec 21, 2023 | 4.03B | -11.96% |
| Dec 28, 2022 | 4.58B | -9.14% |
| Dec 30, 2021 | 5.04B | -15.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 109.63B |
| Abbott Laboratories (Pakistan) | 86.52B |
| AGP Limited | 53.63B |
| The Searle Company | 53.12B |
| Highnoon Laboratories | 51.30B |
| Citi Pharma | 17.71B |
| Ferozsons Laboratories | 16.52B |
| Otsuka Pakistan | 3.41B |